Financial Data and Key Metrics Changes - Organic sales for fiscal year 2025 grew by 2%, with volume growth contributing 1% and price mix adding another 1% [11] - Core earnings per share (EPS) reached $6.83, up 4% year-over-year [14] - Core gross margin declined by 40 basis points, while core operating margin increased by 50 basis points [14] - Adjusted free cash flow productivity was 87%, with $16 billion returned to shareholders, including $10 billion in dividends and $6.5 billion in share repurchases [15] Business Line Data and Key Metrics Changes - Nine out of ten product categories experienced organic sales growth, with Family Care and Personal Healthcare growing in the low single digits [11] - Baby Care saw a decline in organic sales in the low singles [11] - E-commerce sales increased by 12%, now representing 19% of total company sales [12] Market Data and Key Metrics Changes - Focus markets grew organic sales by 2%, with North America up 2% and Europe focus markets up 3% [12] - Greater China organic sales were down 5% year-over-year but improved sequentially, growing 2% in the most recent quarter [12] - Enterprise markets grew by 2%, led by Latin America with 4% organic sales growth [12] Company Strategy and Development Direction - The company is focused on an integrated growth strategy that emphasizes balanced top and bottom line growth and value creation [7][25] - A restructuring program was announced to strengthen execution and improve organizational capabilities [39] - The company aims to capture significant growth opportunities in North America, Europe, and enterprise markets, with potential sales opportunities ranging from $5 billion to $15 billion [24][25] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging macroeconomic environment, including tariffs, inflation, and geopolitical dynamics, which have impacted category growth [23] - The company expects the market environment to remain volatile and challenging in fiscal year 2026, with guidance for organic sales growth in the range of flat to 4% [45][46] - Management emphasized the importance of creating "tailwinds" through innovation and strategic investments to drive growth [58] Other Important Information - The company plans to reduce up to 7,000 non-manufacturing roles, or roughly 15% of its current non-manufacturing workforce, as part of the restructuring efforts [42] - The transition of leadership from Jon Moeller to Shailesh Jujurukar is planned for January 1, 2026, with a focus on continuity and strategic execution [5][56] Q&A Session Summary Question: Insights on Shailesh's leadership and tailwind creation efforts - Management highlighted Shailesh's extensive experience and leadership capabilities as key to driving future growth and value creation [56][58] Question: Addressing the narrowing performance gap in North America - Management acknowledged the reduction in category growth rates and the need to regain superiority in certain categories to widen the performance gap [65][66] Question: Timing and impact of restructuring on organizational capabilities - Management explained that the restructuring aims to enhance decision-making and efficiency, leveraging technology to break down silos within the organization [81][84]

Financial Data and Key Metrics Changes - Organic sales for fiscal year 2025 grew by 2%, with volume growth contributing 1% and price mix adding another 1% [8][12] - Core earnings per share (EPS) reached $6.83, up 4% year-over-year [12][17] - Core gross margin declined by 40 basis points, while core operating margin increased by 50 basis points [12][18] - Adjusted free cash flow productivity was 87% for the year [13] Business Line Data and Key Metrics Changes - Nine out of ten product categories experienced organic sales growth, with Family Care and Personal Healthcare growing in the low single digits [9][10] - Baby Care saw a decline in organic sales in the low single digits [10] - E-commerce sales increased by 12%, now representing 19% of total company sales [10] Market Data and Key Metrics Changes - Focus markets grew organic sales by 2%, with North America and Europe focus markets up by 2% and 3% respectively [10] - Greater China organic sales were down 5% year-over-year but improved sequentially, growing 2% in the most recent quarter [10][15] - Enterprise markets grew by 2%, led by Latin America with 4% organic sales growth [10] Company Strategy and Development Direction - The company is focused on balanced top and bottom line growth, emphasizing the need for brands to lead market growth rather than just gaining market share [4][22] - A restructuring program was announced to strengthen execution of the integrated strategy, focusing on portfolio management, supply chain efficiency, and organizational design [20][35] - The company aims to create $10 billion to $15 billion in sales opportunities in enterprise markets by increasing per capita consumption [21] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging operating environment, including consumer anxiety due to tariffs, inflation, and geopolitical issues [20][42] - The company expects the market environment to remain volatile and challenging in fiscal year 2026, with guidance for organic sales growth in the range of flat to 4% [42][43] - Management emphasized the importance of creating internal tailwinds to drive growth despite external challenges [56] Other Important Information - The company plans to return approximately $15 billion to shareholders in fiscal year 2026 through dividends and share repurchases [47] - The transition of leadership to Shailesh Jujurukar as the new CEO is planned for January 1, 2026, with John Moeller moving to Executive Chairman [3][49] Q&A Session Summary Question: Insights on Shailesh's attributes and goals for the transition - Management highlighted Shailesh's extensive experience and successful leadership in key business areas as reasons for his selection as the next CEO [54][55] Question: Tailwind creation efforts for fiscal year 2026 - Management discussed the restructuring program as a means to build financial headroom for innovation and commercialization, aiming to create internal growth drivers [56][57] Question: Addressing the narrowing performance gap in North America - Management acknowledged the reduction in category growth rates and the need to regain superiority in certain categories to enhance growth [63][65] Question: Timing of the CEO change and organizational capabilities - The timing of the leadership transition was deemed appropriate given the company's strong performance and strategic positioning [78][79] - Management emphasized the importance of breaking down silos within the organization to enhance decision-making and efficiency [81][82]

Summary of Procter & Gamble Conference Call Company Overview - **Company**: Procter & Gamble (P&G) - **Event**: Deutsche Bank Global Consumer Conference Key Points Financial Performance - P&G achieved six consecutive years of 4% or better organic sales growth, with a 2% organic sales increase through March in fiscal year 2025, aligning with guidance [4][5] - Core EPS growth averaged nearly 8% over the past eight years, with a 3% growth in the first three quarters of fiscal year 2025, within the 2% to 4% guidance range [5][6] - Over three quarters, P&G returned more than $13 billion to shareholders through dividends and share repurchases, marking the 69th consecutive annual dividend increase [6] Market Challenges - Increased market volatility in fiscal year 2025, particularly in the U.S. and Europe, with growth rates slowing from around 4% to about 2% [7][8] - Ongoing geopolitical tensions, trade tariffs, and inflation are impacting consumer behavior and market dynamics [8][9] - Anticipated headwinds from tariffs estimated at approximately $600 million before tax for fiscal year 2026 [9] Growth Opportunities - Significant market potential identified in North America ($5 billion) and Europe ($10 billion) through increased household penetration of P&G brands [9][10] - Enterprise markets present a sales opportunity of $10 billion to $15 billion by driving per capita consumption to levels seen in Mexico [11][22] Strategic Initiatives - P&G is implementing a two-year non-core restructuring program focusing on portfolio choices, supply chain restructuring, and organizational design changes [13][15] - The restructuring program aims to reduce up to 7,000 non-manufacturing roles (approximately 15% of the workforce) and is expected to incur costs between $1 billion and $1.6 billion before tax [15][16] - Continued investment in innovation and productivity to enhance operational efficiency and support growth [12][19] Integrated Growth Strategy - P&G emphasizes the importance of delivering "irresistible superiority" across five vectors: product, package, brand communication, retail execution, and value [17][18] - Recent innovations include the launch of Oral B's advanced power toothbrush and Ariel's Big One Pods, which have contributed to market growth [27][30] - The company is leveraging digital tools and AI to enhance advertising effectiveness and optimize supply chain operations [36][38] Future Outlook - P&G expects market growth to stabilize at 3% to 4% over the next 12 to 18 months, despite current short-term volatility [61][62] - The focus remains on maximizing innovation and investment flexibility to navigate market uncertainties [65][66] - The majority of restructuring benefits are anticipated to materialize in fiscal year 2027 [67] M&A Strategy - P&G does not foresee the need for transformational M&A as part of its growth strategy, focusing instead on bolt-on acquisitions to enhance its existing portfolio [55][56] Additional Insights - The company is actively managing its portfolio, including exiting certain markets and divesting underperforming brands to focus on high-growth opportunities [11][12] - P&G's commitment to cash returns to shareholders remains strong, despite the restructuring efforts [16]